Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000930413-11-007995
Filing Date
2011-12-20
Accepted
2011-12-20 12:18:02
Documents
2
Period of Report
2011-12-19

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT c67918_form3.html 3  
1 OWNERSHIP DOCUMENT c67918_form3.xml 3 1629
2 c67918_ex24-1.htm EX-24.1 7056
  Complete submission text file 0000930413-11-007995.txt   10380
Mailing Address 20 KINGSBRIDGE ROAD ATT: GENERAL COUNSEL PISCATAWAY NJ 08854
Business Address 20 KINGSBRIDGE ROAD ATT: GENERAL COUNSEL PISCATAWAY NJ 08854 732-980-4500
ENZON PHARMACEUTICALS INC (Issuer) CIK: 0000727510 (see all company filings)

EIN.: 222372868 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 20 KINGSBRIDGE ROAD PISCATAWAY NJ 08854
Business Address
Daly Timothy (Reporting) CIK: 0001535896 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-12957 | Film No.: 111271301